Results 191 to 200 of about 1,133,081 (254)
Use and Out-of-Pocket Costs of Inhaler Devices by Payer Type and Estimated Carbon Dioxide Emissions.
Qato DM +5 more
europepmc +1 more source
Inability of Physicians to Use Metered-Dose Inhalers
The effectiveness of antiasthmatic therapy with metered-dose inhalers (MDIs) is usually limited by defective inhalational technique. This study surveyed the MDI inhalation performance and knowledge of 100 physicians whose performance (demarcated into six stages) and knowledge scores correlated (r = 0.33, p < 0.001).
Ip, M +8 more
exaly +6 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Metered dose inhalers: A need for dose counters
Respirology, 2005Objectives: This study investigated the ability of patients to assess when a metered dose inhaler (MDI) is empty.Methodology: A total of 17 patients assessed, by shaking, the number of doses remaining in a salbutamol MDI that had been partially emptied.
Shaun, Holt +4 more
openaire +2 more sources
The rejuvenated pressurised metered dose inhaler
Expert Opinion on Drug Delivery, 2007The pressurised metered-dose inhaler (pMDI) has now been available for 50 years. Once regarded as an inefficient and difficult-to-use device, the technology has evolved significantly over the last few years, particularly since the introduction of novel formulations containing hydrofluoroalkane (HFA) propellants.
John, Bell, Steve, Newman
openaire +2 more sources
Floating Patterns of Metered Dose Inhalers
Journal of Asthma, 1997As long as metered dose inhalers have existed, patients have sought a reliable method to determine if a given canister was still potent. Concerning beta agonists, the answer to this question may be lifesaving. Issues of compliance have made dating canisters or counting doses impractical.
B L, Wolf, K R, Cochran
openaire +2 more sources
Nonprescription Epinephrine Metered-Dose Inhaler: To Be or Not To Be
Pediatric Allergy, Immunology, and Pulmonology, 2014A new product, Epinephrine HFA, is being considered by the Food and Drug Administration (FDA) for marketing approval as a nonprescription bronchodilator inhaler for the treatment of the “temporary relief of mild symptoms of intermittent asthma in adults and children 12 years of age and older.” This product would serve as a ...
Kathryn, Blake, Hengameh, Raissy
openaire +2 more sources
The Continued Need for Metered Dose Inhalers
Journal of Aerosol Medicine, 1995The metered dose inhaler (MDI) is currently the most widely used device in the treatment of adult asthma. It is the delivery system of choice in general practice throughout the world where both MDIs and powder inhalers are available. Up to 70% of all UK adult asthma prescriptions are for an MDI and worldwide the figures are likely to be higher. The MDI
openaire +2 more sources
Spacer Devices for Metered Dose Inhalers
Clinical Pharmacokinetics, 2004Spacer devices are attachments to the mouthpieces of pressurised metered dose inhalers (pMDIs), and range from tube spacers with a volume of
openaire +2 more sources
Principles of Metered-Dose Inhaler Design
Respiratory Care, 2005The pressurized metered-dose inhaler (pMDI) was introduced to deliver asthma medications in a convenient and reliable multi-dose presentation. The key components of the pMDI device (propellants, formulation, metering valve, and actuator) all play roles in the formation of the spray, and in determining drug delivery to the lungs.
openaire +2 more sources
Metered-Dose Inhalers, Dry Powder Inhalers, and Transitions
Respiratory Care, 2000Since 1956, the pMDI has become the most commonly prescribed and used aerosol device in the world. While concerns about global warming have led to a worldwide ban of CFCs, new HFA-propelled pMDIs are in development, requiring an evolutionary transition in the technology.
openaire +2 more sources

